Biology of the papillomavirus E5 oncoprotein family
Biology of the papillomavirus E5 oncoprotein family
批准号:
7227132
负责人:
Richard Schlegel
金额:
$48.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-01-01 至 2011-02-28
关键词:
AlkalinizationAnchorage-Independent GrowthAneuploidyAppendixBindingBiologicalBiological AssayBiologyC-terminalCancer EtiologyCaveolinsCell Differentiation processCellsCervicalCessation of lifeCharacteristicsCollaborationsCommunicationComplexConnexinsContact InhibitionDetergentsDifferentiation and GrowthDisruptionEndosomesEpidermal Growth Factor ReceptorEpidermisEvolutionFamilyFibroblastsGap JunctionsGenesGoalsGrantGrowthGrowth Factor ReceptorsHumanHuman papillomavirus 16In VitroInfectionIntercellular JunctionsIntracellular MembranesKnockout MiceKnowledgeLaboratoriesLinkMaintenanceMalignant NeoplasmsMalignant neoplasm of cervix uteriMeasuresMediatingMembraneMembrane LipidsMembrane MicrodomainsModelingMolecular TargetMonitorMusNeoplasmsNumbersOncogene ProteinsOncogenesOncogenic VirusesPapillomavirusPhenotypePropertyProtein BindingProteinsRangeResearch PersonnelRiskRoleSignal PathwaySignal TransductionSolubilitySystemTERT geneTP53 geneTransgenic MiceTransplantationTumor Suppressor ProteinsTumorigenicityVesicleVirusWomananticancer researchbasecaveolin 1cell growthcostdesignin vivoinsightkeratinocytemouse modelmutantprogramsprotein functionresearch studytraffickingtumorvacuolar H+-ATPase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The high-risk papillomaviruses are critical etiologic agents in human malignancy, most importantly in cervical cancer. These oncogenic viruses encode the E6 and E7 proteins that have been shown to modulate cell growth and differentiation, target the p53 and Rb tumor suppressor proteins, and induce the hTERT gene and cellular immortalization. In addition to the E6 and E7 proteins, the high-risk papillomaviruses also encode the hydrophobic, membrane-associated E5 protein. In recent months, several studies have established that the evolution of the E5 protein is tightly linked to that of the E6 protein and that the E5 genes of high-risk papillomaviruses have characteristics that separate them from those of low-risk viruses. The high-risk HPV-16 E5 protein has a wide spectrum of biological activities, ranging from alterations of growth factor receptor turnover, MHC transport, endosome acidification, anchorage-independent growth, and intercellular junction communication. Previously we have shown that the E5 protein binds a component of the V-ATPase complex and interferes with endosome acidification, thereby giving some insight into how E5 might potentiate the signaling of growth factor receptors. In the current proposal, we have discovered additional targets for E5, including caveolin and a 116 kDa cellular protein. Based upon our accumulated knowledge regarding the detergent solubility properties of E5 and the identified E5-associated proteins, we hypothesize that E5 partitions into membrane lipid rafts and associates with proteins that are resident in these signaling platforms. We have constructed a model that conceptually links the identified E5 targets with the plethora of known E5-induced cellular phenotypes and have designed experiments based upon this model. The specific delineation of how E5 is targeted to rafts, how it binds to specific raft-resident proteins, and how it interferes with the functions of these proteins is the focus of this grant. It is anticipated that insights into E5 functions will illuminate its linkage to HPV-induced malignancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8899468
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8727495
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Conditionally reprogrammed cells as a novel tool for biobanking
-
批准号:8547303
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2013
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8516613
-
项目类别:
-
资助金额:$39.21万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8725249
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8322566
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
Emerging Papillomaviruses in Immunosuppressed Dogs
-
批准号:8137493
-
项目类别:
-
资助金额:$39.94万
-
财政年份:2011
-
负责人:Richard Schlegel
-
依托单位:
A topical treatment for genital papillomavirus infections
-
批准号:7286845
-
项目类别:
-
资助金额:$17.99万
-
财政年份:2006
-
负责人:Richard Schlegel
-
依托单位:
A topical treatment for genital papillomavirus infections
-
批准号:7174571
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2006
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:6757107
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7114631
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7274152
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
Treatment of Cervical Cancer with Artemisinin
-
批准号:6948533
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7115758
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:6949542
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
HPV E6 protein regulation of the hTERT promoter
-
批准号:7488862
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
Treatment of Cervical Cancer with Artemisinin
-
批准号:6823604
-
项目类别:
-
资助金额:$23.28万
-
财政年份:2004
-
负责人:Richard Schlegel
-
依托单位:
DNA CONFORMATION DEPENDENT REGULATOR OF GENE EXPRESSION
-
批准号:2896082
-
项目类别:
-
资助金额:$23.6万
-
财政年份:1997
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE
-
批准号:2098706
-
项目类别:
-
资助金额:$25.16万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
CANINE ORAL PAPILLOMAVIRUS--MODEL FOR A VACCINE
-
批准号:2098705
-
项目类别:
-
资助金额:$23.88万
-
财政年份:1992
-
负责人:Richard Schlegel
-
依托单位:
海外基金